Drug intelligence / Profile preview

CalxPlus

Development stage
Unknown
Lead developer
Ceres Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

CalxPlus is a dietary mineral supplement developed and marketed by Ceres Pharma, primarily in the Belgian and European markets. It is formulated as a combination of calcium carbonate, vitamin D3 (cholecalciferol), and vitamin K1 (phytomenadione). The supplement is intended to support bone health and prevent osteoporosis by providing essential components for bone mineralization. Calcium carbonate provides elemental calcium (600 mg), while vitamin D3 (10 μg) enhances intestinal calcium absorption. Vitamin K1 (65 μg) is included to facilitate the binding of calcium to the bone matrix via the carboxylation of osteocalcin. CalxPlus is available in various oral formulations, including chocolate-flavored chewable tablets and capsules, specifically targeting individuals with calcium deficiency or those requiring bone density support.

Brand names
CalxPlus
Other names
calcium supplement
02

Targets

GGCX (Vitamin K-dependent gamma-glutamyl carboxylase)VDR (Vitamin D receptor)

Beyond the preview

Go deeper on CalxPlus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CalxPlus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call